Abu Dhabi’s MBZUAI Plays A Key Role
Amidst rising healthcare costs and mounting environmental challenges, Artificial intelligence (AI) is revolutionising healthcare access, extending services to underserved communities, and bolstering preventive care and diagnosis.
Given the above scenario, Abu Dhabi-based Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) is at the forefront of groundbreaking research in the GCC region involving AI and healthcare.
Combatting Malaria
In the fight against malaria, AI-powered applications developed by MBZUAI scientists, with support from the Reaching the Last Mile initiative, aid Indonesian health officials in mitigating the disease’s impact.
These applications generate real-time digital representations of environments through sensory data fusion, enabling precise forecasting of malaria outbreaks and proactive intervention strategies.
Predictive Healthcare
AI’s predictive capabilities empower proactive medical interventions. MBZUAI researchers, collaborating with the University of Oxford, employ machine learning and computer vision to detect cardiovascular disease early from CT scans.
This innovation promises swift analysis and personalised treatment plans, potentially benefiting millions worldwide.
Remote Patient Monitoring
AI-driven remote monitoring systems track vital signs and health metrics from afar, offering real-time insights into patient well-being.
Particularly beneficial for chronic conditions and remote areas, these technologies enhance healthcare efficiency and reduce hospital readmissions, ensuring timely interventions.
Drug Development Acceleration
Quris-AI and MBZUAI’s collaboration aims to revolutionise drug development through AI. The Bio-AI Centre of Excellence in Abu Dhabi endeavours to accelerate the creation of safer, personalised medications tailored to the MENA region’s diverse populations.
This initiative harnesses AI’s predictive capabilities to streamline clinical trials and drug safety assessments.
Personalised Treatments
AI’s analytical prowess enables tailored medical interventions, from precise cancer therapies to predicting drug responses based on individual characteristics.
MBZUAI’s focus on genome mapping and AI-powered drug discovery partnerships promises more effective and personalised treatments for patients, contributing to transformative healthcare outcomes.
In the quest for equitable healthcare access, AI is emerging as a potent tool, breaking barriers and ushering in a new era of preventive care and personalised medicine.
Featured image: AI is ushering in a new era of preventive care and personalised medicine. Credit: Tim Cooper
